by EpicentRx | May 31, 2024 | Blog
The MD Anderson tagline is “Making Cancer History”, which applies to sarcoma investigator and MD Anderson Associate Professor, Dr. Anthony P. Conley. The man of the moment, Dr. Conley is spotlighted in a just-released MD Anderson newsletter entitled Newest Research in...
by EpicentRx | May 31, 2024 | Blog
by EpicentRx | May 31, 2024 | Blog
BIO, which stands for Biotechnology Innovation Organization, is a signature biotech partnering conference that will take place this year from June 3rd-6th at the downtown San Diego Convention Center, a few miles from EpicentRx HQ. EpicentRx puts the “IO” in BIO: the...
by EpicentRx | May 30, 2024 | Blog
The term, disruptive innovation, reminds us of what the late, great funnyman and real disruptive innovator, Robin Williams, once said about drugs: “When I was growing up, they used to say, ‘Robin, drugs can kill you.’ Now that I’m 58 my doctor is telling...
by EpicentRx | May 29, 2024 | Blog
“BOOM!” emailed Dr. Anthony P. Conley to us after having received notice that he was selected to give an oral presentation on lead EpicentRx therapy, AdAPT-001, plus a checkpoint inhibitor at #ASCO2024. Actually, the “BOOM!” was bigger than that, both literally...
